VP, Corporate Strategy
With nearly 20 years in small molecule, protein, and gene therapy development, I lead teams from preclinical stages to proof-of-concept trials. My expertise in international drug licensing has facilitated successful collaborations and agreements. I excel at spotting market opportunities and developing strategic plans to maximize project value and foster win-win outcomes. My strong communication and coordination skills drive teams to achieve strategic objectives across diverse cultures.